Radiopharm Theranostics' market value is the price at which a share of Radiopharm Theranostics trades on a public exchange. It measures the collective expectations of Radiopharm Theranostics Limited investors about its performance. Radiopharm Theranostics is trading at 4.93 as of the 24th of January 2026; that is 2.38 percent down since the beginning of the trading day. The stock's open price was 5.05. With this module, you can estimate the performance of a buy and hold strategy of Radiopharm Theranostics Limited and determine expected loss or profit from investing in Radiopharm Theranostics over a given investment horizon. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates.
Symbol
Radiopharm
Radiopharm Theranostics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Radiopharm Theranostics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Radiopharm Theranostics.
0.00
10/26/2025
No Change 0.00
0.0
In 3 months and 1 day
01/24/2026
0.00
If you would invest 0.00 in Radiopharm Theranostics on October 26, 2025 and sell it all today you would earn a total of 0.00 from holding Radiopharm Theranostics Limited or generate 0.0% return on investment in Radiopharm Theranostics over 90 days.
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Radiopharm Theranostics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Radiopharm Theranostics Limited upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Radiopharm Theranostics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Radiopharm Theranostics' standard deviation. In reality, there are many statistical measures that can use Radiopharm Theranostics historical prices to predict the future Radiopharm Theranostics' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Radiopharm Theranostics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Radiopharm Theranostics January 24, 2026 Technical Indicators
Radiopharm Theranostics is extremely dangerous given 3 months investment horizon. Radiopharm Theranostics maintains Sharpe Ratio (i.e., Efficiency) of 0.0559, which implies the firm had a 0.0559 % return per unit of risk over the last 3 months. We were able to break down twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.15% are justified by taking the suggested risk. Use Radiopharm Theranostics Risk Adjusted Performance of 0.0451, semi deviation of 8.09, and Coefficient Of Variation of 2064.11 to evaluate company specific risk that cannot be diversified away. Radiopharm Theranostics holds a performance score of 4 on a scale of zero to a hundred. The company holds a Beta of 1.27, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Radiopharm Theranostics will likely underperform. Use Radiopharm Theranostics potential upside, and the relationship between the total risk alpha and kurtosis , to analyze future returns on Radiopharm Theranostics.
Auto-correlation
0.24
Weak predictability
Radiopharm Theranostics Limited has weak predictability. Overlapping area represents the amount of predictability between Radiopharm Theranostics time series from 26th of October 2025 to 10th of December 2025 and 10th of December 2025 to 24th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Radiopharm Theranostics price movement. The serial correlation of 0.24 indicates that over 24.0% of current Radiopharm Theranostics price fluctuation can be explain by its past prices.
Correlation Coefficient
0.24
Spearman Rank Test
0.3
Residual Average
0.0
Price Variance
1.12
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Radiopharm Pink Sheet Analysis
When running Radiopharm Theranostics' price analysis, check to measure Radiopharm Theranostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Radiopharm Theranostics is operating at the current time. Most of Radiopharm Theranostics' value examination focuses on studying past and present price action to predict the probability of Radiopharm Theranostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Radiopharm Theranostics' price. Additionally, you may evaluate how the addition of Radiopharm Theranostics to your portfolios can decrease your overall portfolio volatility.